Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies

A phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Proc Annu Meet Am Soc Clin Oncol. 1996; 15:A1566.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.